Dear Dr. Roach: Would it be possible for you to explain my recent diagnosis of monoclonal gammopathy of uncertain significance (MGUS)? Apparently, 3% to 5% of the population over the age of 50 show ...

Monoclonal gammopathy is characterized by an abnormal monoclonal (M)-protein in the blood. This protein is associated with renal toxicity related to the underlying gammopathy. "The key finding of our ...

Multiple myeloma is a cancer of the plasma cell. Plasma cells are white blood cells that make antibodies that help to protect us from infections. However, the cells grow too much in myeloma, crowding ...

Retrospective analysis of vaccine antibody titers in patients with different stages of monoclonal plasma cell disorders. Two cycles versus three cycles of neoadjuvant sintilimab plus platinum-doublet ...

Watch Dr. Neha S. Korde, an assistant professor in multiple myeloma service in the Division of Hematology at Memorial Sloan Kettering Cancer Center, present on MGUS/smoldering myeloma. Multiple ...

Speakers on precursor disease addressed distinctions between MGUS and smoldering multiple myeloma, risk stratification, and new thinking on the role of immunological aging, especially how it affects ...

Renal disease is a rare but potentially severe manifestation of IgG4-RD. An elderly man with immunoglobulin G4-related disease (IgG4-RD) with kidney involvement and monoclonal gammopathy was ...

We developed precompiled lexicons and classification rules as features for the following ML classifiers: logistic regression, random forest, and support vector machines (SVMs). These features were ...

As a part of its “Speaking Out” video series, on behalf of the International Myeloma Foundation, CURE® spoke with their chief medical officer, Dr. Joseph Mikhael about the precursors to multiple ...

Share on Pinterest Researchers continue to study the risk factors for the blood cancer multiple myeloma. Abraham Gonzalez Fernandez/Getty Images Smoking, poor sleep, and obesity may increase the risk ...